Actively Recruiting
Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
Led by Rambam Health Care Campus · Updated on 2025-08-07
250
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Supportive and palliative care play an important role in cancer treatment, and when introduced early can improve quality of life and may even increase median survival rates, as shown in patients with advanced lung cancer. Complementary and integrative medicine (CIM) is a popular supportive approach among oncology patients and is on the rise worldwide. In many countries, homeopathy is being one the CIM methods integrated with a general sense that this treatment is beneficial to the well-being and quality of life (QoL) of cancer patients. In this observational study we will evaluate the feasibility of integrating homeopathic approach in patients attending the complementary and integrative oncology service at the division of oncology in Rambam Health Campus in Haifa, Israel, a major referral comprehensive cancer center. This observational study will evaluate three main ingredients of acceptance: * Obtaining the reasons that patients willing to integrate this supportive approach * Patient acceptance of this supportive approach as well as compliance with the homeopathic approach * Obtaining retrospective subjective information from the patients through validated quality of life questionnaires. (MYCaW, Distress Thermometer, and ESAS-R) Measures which are used routinely in integrative oncology encounters.
CONDITIONS
Official Title
Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Ability to read, write, and understand the Hebrew language
- Patients treated at the Division of Oncology in Rambam Health Campus
- Performance status of ECOG 0-2
- Consent to participate in the study
You will not qualify if you...
- Inability to understand the intent of the study and follow the instructions
- Diagnosis of active psychosis, altered mental state, or severe cognitive impairment confirmed by the attending physician
- Frailty, ECOG worse than 2, or other unstable medical conditions including acute illness, fever, or unclear rash that preclude participation in an interview lasting 15-30 minutes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rambam Medical Center
Haifa, Israel, 30900
Actively Recruiting
Research Team
M
Moshe Frenkel, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here